% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@BOOK{Lucas:472123,
author = {Gisriel, Christopher and Fromme, Petra and Martin-Garcia,
Jose M.},
editor = {Lucas, Alexandra R.},
title = {{M}ethods for {C}rystallization and {S}tructural
{D}etermination of {M}-{T}7 {P}rotein from {M}yxoma {V}irus},
volume = {2225},
address = {New York, NY},
publisher = {Springer},
reportid = {PUBDB-2021-04846},
isbn = {978-1-0716-1011-4 (print)},
series = {Methods in Molecular Biology},
pages = {297},
year = {2021},
abstract = {The myxoma virus has become of interest in human medicine
in the last two decades as it has the ability to infect many
types of human cancer cells and is being used as a platform
to develop viro-therapeutic agents that suppress aggressive
and damaging immune responses and inflammation. Furthermore,
the myxoma virus encodes proteins that have strong
immunosuppressive effects, and several of the myxoma
virus-encoded immunomodulators are being developed to treat
systemic inflammatory syndromes such as cardiovascular
disease and transplant rejection. Myxoma virus encodes the
M-T7 protein, the most abundantly secreted protein expressed
in myxoma virus-infected cells, originally identified as a
rabbit species-specific interferon-gamma (IFN-γ) receptor
homolog and as a chemokine-modulating protein binding a wide
range of mammalian chemokines. M-T7 is a critical virulence
factor for viral pathogenesis that increases virus lethality
when expressed. Although M-T7 has been extensively studied
using biochemical and biophysical techniques and its
interactome map is well known, its three-dimensional (3D)
structure remains elusive. Obtaining the 3D structure of
M-T7 would be greatly beneficial and is a crucial step
toward advancing M-T7 research through understanding the
molecular function and activity of M-T7 as a novel
therapeutic reagent and to rationally develop this protein
as a drug. This chapter provides an overview of the
structural determination techniques, especially X-ray
crystallography, that can be applied toward the goal of
achieving the first high-resolution structure of M-T7. In
addition, details of up-and-coming methods are discussed,
including X-ray diffraction at X-ray free electron lasers
(XFELs), nuclear magnetic resonance (NMR), cryo-electron
microscopy (cryo-EM), Micro-electron diffraction (Micro-ED),
and small-angle X-ray scattering (SAXS), and their potential
applications to M-T7 structural biology.},
cin = {EMBL-User},
cid = {I:(DE-H253)EMBL-User-20120814},
pnm = {6G3 - PETRA III (DESY) (POF4-6G3)},
pid = {G:(DE-HGF)POF4-6G3},
experiment = {EXP:(DE-H253)P-P12-20150101},
typ = {PUB:(DE-HGF)3},
pubmed = {pmid:33108661},
doi = {10.1007/978-1-0716-1012-1_8},
url = {https://bib-pubdb1.desy.de/record/472123},
}